{"title":"Prioritising patients back to work: a small step for NICE, a giant leap for the NHS","authors":"Audun Brendbekken, Anand Bhopal","doi":"10.1136/bmj.q2841","DOIUrl":null,"url":null,"abstract":"Announcing investments in a five year trial of tirzepatide (a glucagon-like peptide-1 analogue weight loss drug), health secretary Wes Streeting showed support for prioritising patients able to return to work, saying that obesity was not only a health issue but also “holding back our economy.”12 Incorporating the economic benefits of returning people to work sooner echoes concerns raised in the Darzi report, commissioned by Streeting. …","PeriodicalId":22388,"journal":{"name":"The BMJ","volume":"32 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-12-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The BMJ","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/bmj.q2841","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Announcing investments in a five year trial of tirzepatide (a glucagon-like peptide-1 analogue weight loss drug), health secretary Wes Streeting showed support for prioritising patients able to return to work, saying that obesity was not only a health issue but also “holding back our economy.”12 Incorporating the economic benefits of returning people to work sooner echoes concerns raised in the Darzi report, commissioned by Streeting. …
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
